An FDA warning letter to for a Canadian dietary supplement manufacturer won't rise to the same level of controversy as the Trump administration's tariffs on some imports from the country, but the firm no longer is exporting some of its products to the US.
FDA Warning, Not Tariffs, Stop Canadian Supplement Firm 'Drug' Exports To US
Bill Beauty and Health Products, provider of the Bill Natural Sources supplements line and of contract manufacturing for other supplement marketers, informed FDA that it won't ship to the US its supplements that an agency inspection showed are not up to drug specs.
More from International
PAGB CEO Michelle Riddalls and ISF president emeritus David Webber have been awarded OBEs for their services to consumer health and self-care.
A round-up of the latest consumer health industry appointments: GSCF names next director general, MENAP-SCI elects chairman; Clasado hires BD director.
A slowdown in China and the US, along with signs of a weaker cough & cold season in the latter, has led Bayer Consumer Health to lower its full-year sales guidance.
Proposed administrative order likely is first to prompt opposition from OTC industry or other stakeholders potentially delaying or deferring the agency’s expectation for moving its proposal to a deemed final order effective one year after it would be published.
More from Geography
Oral pseudoephedrine decongestants marketed by Kenuve, Haleon and Opella, amongst others, are now only available with a doctor's prescription in France.
Bayer Consumer Health snaps up digital therapeutic Cara Care for its Precision Health business with an eye to developing its self-care capabilities.
FSA now aims to send the first recommendations for the authorization of CBD novel food products to UK government ministers in 2025, according to its most recent board meeting. The agency is closely scrutinizing trace THC levels and is planning to ban use of CBD food products by under 18s.